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Abstract
Background: Kawasaki disease is a common childhood vasculitis which may result in cardiovascular morbidity if
not adequately treated. Its epidemiology in the African region is not well described. Its features may mimic other
childhood infections and hemoglobinopathies and it is rarely diagnosed in the East African region. These are the
first reports of this disease from Tanzania.
Case presentation: We present two cases of complete Kawasaki disease seen over a 2 year period and diagnosed
as per the criteria defined by the American Heart Association. One child was and infant and the other a 3 year old.
Both of them presented with a prolonged fever and mucocutaneous findings. None of the children developed
coronary artery aneurysms. One was treated with aspirin alone and the other with both aspirin and intravenous
immunoglobulin. Both children had complete recovery and did not have any cardiovascular sequelae.
Conclusion: Kawasaki disease may be more common in the East African region than previously thought. It should
be considered as a differential diagnosis in children who present with a prolonged fever of greater than 5 days and
mucocutaneous findings. More awareness about this condition, its epidemiology, diagnosis and management are
required in order to prevent the cardiovascular morbidity associated with it.
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Background
Kawasaki disease is one of the most common vasculitides
in childhood. It occurs predominantly in infants and
young children and has long term cardiovascular morbidity due to coronary artery lesions if not adequately treated
[1]. It is the leading cause of acquired heart disease in children in developed countries. The highest incidence is in
Asia with almost 1 in a 100 children in Japan having the
disease by age 5 [2]. In Africa, two cases were reported in
South Africa in Caucasian children in 1980 but the first
case in an African child was reported in Ivory Coast in
1981. Despite of sporadic cases being reported across
many countries in Africa, mainly North Africa and the
West African region, the epidemiological data for KD is
limited for African countries [3–5].
The etiology of the disease remains unknown and several hypothesis exist in trying to explain the cause.
* Correspondence: mariam.noorani@akhst.org
Aga Khan Hospital, Dar es Salaam, Tanzania

Epidemiologic data suggest that an infectious agent may
be causing the disease in genetically susceptible individuals [6]. The classic presentation of the disease occurs in
children below 5 years. This suggests that there is an environmental trigger to which children mount an immune
response after which the disease no longer manifests [7].
Postulated infectious agents include variants of normal
flora which are induced by environmental factors such
as improved hygiene [8]. Pathogenetic mechanisms
postulated to result in endothelial injury include that of
a protein homeostasis system in which immune cells
target pathogenic proteins bound to endothelial cells
resulting in host cell injury [9].
The initial symptoms are of a febrile illness lasting longer
than 5 days with other mucocutaneous features including a
rash, conjuctivitis and adenopathy. Diagnostic criteria exist
to make a diagnosis of both complete and incomplete
forms of disease [10]. If left untreated, the symptoms
resolve in about 10 days. However, the coronary artery
lesions may lead to long term cardiovascular complications
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including myocardial infarction, heart failure and arrhythmias. Treatment in the acute phase reduces the incidence
of coronary artery lesions from 25 to 30% to 3–5% [11].
Currently, the recommended treatment is intravenous
immunoglobulin in addition to acetylsalicylic acid at high
doses [10].
In sub-saharan Africa, children suffer from many tropical
and infectious diseases that present with symptoms similar
to those of kawasaki disease such as fever, irritability and a
rash. Common conditions include malaria, typhoid fever,
meningitis and viral exanthems such as measles and roseola infantum. Other conditions that may mimic this disease include sickle cell dactylitis and infection with group
A beta hemolytic streptococcus. A high index of suspicion
is hence required to identify cases of kawasaki disease and
institute early treatment.
We report here 2 cases of kawasaki disease seen at our
institution that met diagnostic criteria defined by the
American Heart Association. These are the first reports
in published literature from the East African region.
Case presentations
Case 1

A.M was a 3 year old female child of African ethnicity
who presented in July 2012 with a 8 day history of high
grade fever and a 1 day history of swelling of the hands
and feet. (Table 1 – timeline of case 1). She had received
oral antibiotics, anti malarials and antihistamines with no
improvement in symptoms. Her past medical history had
been uneventful and her vaccinations were uptodate.
On examination, she was alert, had dry, red lips and
non pitting edema on her hands and feet. She had cervical nodes measuring about 0.5 cm. Her cardiovascular
exam was normal. She was admitted for further work up
for the cause of her fever.
Her results showed an elevated WBC count of 36,000/
μl, Hb of 9.1 g/dl and platelets of 380,000/μl. Her CRP
was 173 mg/l. Malaria antigen and slide were both negative. Her urinalysis was normal. She was started empirically on ceftriaxone for presumed bacteremia and blood
and urine cultures were sent. A differential diagnosis of
sickle cell anaemia with dactylitis was also made and a
peripheral smear, reticulocyte count and sickling test
were requested. The reticulocyte count was low with a
percentage of 0.38. Sickling test was negative and the
peripheral smear was normal.
She continued to have fever spikes despite the antibiotics and then developed a maculopapular hyperemic
rash on her chest. A diagnosis of incomplete kawasaki
disease was now made which met 3 out of the 5 required
criteria. An echocardiogram was done which showed
normal coronary arteries. High dose aspirin was started
at 80 mg/kg/day. IVIG was not available at the institution at that time. A repeat complete blood count showed
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some improvement in white blood cells (28000/μl) but
elevated platelets of 644000/μl. The blood and urine culture were both reported as negative after 48 h.
The child was then flown out to Nairobi, Kenya for
IVIG treatment which she received uneventfully. She
was discharged on low dose aspirin and subsequent
echocardiograms remained normal.
Case 2

W.I was an 8 month old infant of African ethnicity who
presented in August 2013 with a 6 day history of a high
grade fever with temperatures upto 39 degrees celsius.
(Table 2 – Timeline of case 2). This was associated with
redness of the eyes, lips and mouth. He had been treated at
various health facilities with antimalarials and 2 antibiotics:
cefalexin and coamoxiclav. He had also received paracetamol, ibuprofen and diclofenac injections to control the
fever. His past medical history was uneventful and his
vaccines were uptodate. He had attained milestones
appropriately.
On examination, the child was irritable and difficult to
console. He was febrile with a temperature of 38.5 0 C
and was not pale. He had dry, cracked, hyperemic lips
and conjuctival injection bilaterally. Cervical nodes were
not palpable. He had a papular rash on the neck and at
the site of the BCG scar. The rest of his physical exam
was normal.
A presumptive diagnosis of incomplete kawasaki disease was made meeting 3 of the five criteria required in
addition to the fever. A complete blood count showed
mild anaemia with normal platelet count. (WBC: 9.07
*103/μl, Hb: 9.3 g/dl, platelets:190,000/μl). Malaria antigen and blood slide were both negative. He was started
on high dose aspirin at 90 mg/kg/day as IV IG was not
available in our institution at that time. An echocardiogram was done which showed normal coronary arteries
and normal cardiac function.
His fever resolved after 72 h and he developed swelling
of the hands and feet which now confirmed the diagnosis
of complete kawasaki disease. The aspirin dose was reduced to 5 mg/kg/day after the fever subsided. The platelet count was repeated and it showed elevated platelets of
742,000/μl. The CRP was also high: 153 mg/l.
On follow up after a week, the limb swelling had
reduced and he had skin exfoliation. His CRP had
reduced to 60 mg/l and the platelets were 605,000/μl.
A follow up echo done after 1 month was normal and
the aspirin was stopped after the hematological parameters had normalised. He has subsequently remained well
with no cardiovascular sequelae.

Discussion and conclusions
Both cases described above presented to us after a prolonged duration of fever and failure to respond to
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Table 1 Timeline of Case 1
Dates

Relevant past medical history and interventions
Previously well child with no chronic disease, growth and development appropriate for age, vaccinations complete as per schedule

Date

Summary from initial and follow up visits

Diagnostic testing

Interventions

July 2012 –
Day 1

8 days of fever
1 day of swollen hands and feet
Received antibiotics, antimalarials, antihistamines
On examination: dry lips, non-pitting edema,
cervical nodes
Diagnosis – probable sickle cell anaemia

WBC – 36,000/μl,
platelets – 380,000/μl,
hemoglobin-9.1 g/dl
Blood cultures – negative
(results on day 5)
Sickling test – negative
Peripheral smear – normal
Reticulocyte count - normal

IV ceftriaxone

Day 3

Persistent fever.
Maculopapular rash on chest.
Diagnosis – probable
Kawasaki meeting 3 of 5 criteria

Echocardiogram – normal coronary
arteries
Repeat blood count: elevated platelets –
644,000/μl

High dose aspirin –80 mg/kg/day

Day 5

Persistent fever

Day 7

Fever resolved

Repeat Echo normal

Discharged on low dose aspirin –
5 mg/kg/day

September
2012

Follow up visit – no signs and symptoms

Echo – normal
WBC and platelets – normal

Aspirin stopped

Flew to Nairobi for IVIG treatment

antimalarials and antibiotics. This is a common presentation also described in case reports from Ghana [3].
The first case was 3 year old child while the second was
an infant. This is in keeping with epidemiologic studies
from Algeria and Japan which have shown that more than
90% of children are less than 5 years of age [2, 5].
The children had the classical mucocutaneous features
that are key to making the diagnosis. The first child had
limb swelling, a skin rash and oral mucosal changes. The
limb swelling was initialy thought to be sickling dactylitis
which is a common condition seen in our environment and
is one of the presenting signs of sickle cell disease [12].
The second child had non purulent conjuctivitis,
swelling of limbs and the skin rash with involvement of
the BCG scar which has been described previously [13].
Hematologic parameters are not diagnostic of kawasaki

disease, however they can assist to confirm or support
the diagnosis. Both our children were admitted with
normal platelet counts which subsequently became
elevated. This is a common finding in the second week
of illness and is used as an adjunct in making diagnosis
of incomplete kawasaki disease [10]. The first child had
an elevated WBC count leading to a diagnosis of
bacteremia and initiation of parenteral antibiotics.
However, the blood culture eventually ruled out a
bacteremia. The CRP was raised for both the cases as
expected and eventually reduced after initiation of
aspirin.
The first case was treated with both aspirin and IVIG
while the second received only aspirin. The role of aspirin remains uncertain in the current era of use of
IVIG, however it still remains as part of the standard

Table 2 Timeline of Case 2
Dates

Relevant past medical history and interventions
Previously well child with no chronic disease, growth and development appropriate for age, vaccinations complete as per schedule

Date

Summary from initial and follow up visits

Diagnostic testing (including dates)

Interventions

August 2013 –
day 1

Fever for 6 days and redness of eyes, lips and mouth.
Treated with antimalarials, antibiotics with no relief
On examination: dry cracked lips, conjuctival injection,
rash at BCG scar site and on the neck
Diagnosis: incomplete kawasaki

Platelets: normal – 190,000/μl
Malaria negative
Echo: normal coronary arteries

High dose aspirin – 90 mg/kg/day

Day 3

Fever resolved
Swelling of hands and feet
Diagnosis: complete kawasaki

Platelets elevated – 743,000/μl
CRP elevated: 153 mg/l

Aspirin reduced to 5 mg/kg/day

Day 7

Swelling subsided
Skin exfoliation

Repeat platelet count: 605,000/μl
CRP: reduced to 60 mg/l

Aspirin continued

Day 30

Follow up visit – no signs and symptoms

Repeat echo: normal
CRP - < 5 mg/l
Platelets: normal range

Aspiring stopped
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treatment protocols. The current treatment: IVIG is an
expensive drug that is not readily available or affordable
to most families in our population. A single vial of 5 g
costs as much as 1 million tanzanian shillings which is
about 450 US dollars. This hampers effective treatment
which is essential to reduce the cardiovascular sequelae.
Other treatment options that could be considered are
use of corticosteroids. A cochrane review of 7 trials
showed benefits of reducing cardiac complications by
using steroids as adjunct therapy to IVIG early in the
course of illness [14]. Use of steroids alone without IVIG
has not been studied. However, in low resource settings
where IVIG is not available, steroids could be used to reduce the cardiovascular morbidity [15]. Other agents such
as infliximab have shown promise as adjuncts to IVIG but
are also not widely available in sub – saharan Africa [16].
The echocardiograms for both children were normal
at baseline and on subsequent follow ups. This was reassuring since the incidence of coronary abnormalities is
as high as 25–30% in patients who are not treated with
IVIG [11]. Echo is a vital modality to follow up the cardiac sequelae in chidlren with kawasaki disease. However, it is not widely available in most resource limited
settings and requires specialised training to operate. In
Tanzania, it is only available at a few referral hospitals in
the cities. This is yet another challenge in providing
long-term care to children with kawasaki disease.
Kawasaki disease has not commonly been described in
sub-saharan Africa. However, these 2 cases were seen over
a 2 year period at a single tertiary institution. This raises
concern about how many missed cases there may be which
are not diagnosed or managed effectively since the fever
and mucocutaneous changes eventually resolve within
3 weeks even without specific treatment. The subsequent
devastating cardiovascular morbidity of this condition in
children with missed diagnosis remains unknown.
The pattern of disease in the setting of tropical infections
like malaria also remains unknown. Kawasaki like
syndromes have been described in adults with HIV
infection especially with severe immunosupression [17].
Similar illness in children infected with HIV has not been
described but may also occur.
We recommend that a diagnosis of kawasaki disease
be entertained for any febrile illness lasting longer than
5 days and presenting with mucocutaneous findings.
Any child presenting with a prolonged fever should
promptly be referred to and evaluated at a tertiary
centre. Doctors and other care providers should be made
familiar with this condition in order to diagnose, treat
and prevent the cardiovascular morbidity and mortality.
Cases that are seen at other institutions should be
published in literature so that the spectrum of the disease, its epidemiologic characteristics and its outcomes
in sub-saharan Africa can be described. Equally
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important is that IVIG be made available at a subsidised
and more affordable cost in order to benefit patients
with kawasaki disease and other autoimmune conditions
where it is indicated.
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